Atnaujinkite slapukų nuostatas

2021 Nelson's Pediatric Antimicrobial Therapy 27th Revised edition [Minkštas viršelis]

Consultant editor , Edited by , Consultant editor , Consultant editor , Consultant editor , Consultant editor , Edited by , Consultant editor , Consultant editor
  • Formatas: Paperback / softback, 362 pages, aukštis x plotis x storis: 171x121x19 mm, weight: 299 g
  • Išleidimo metai: 26-Jan-2021
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610024443
  • ISBN-13: 9781610024440
Kitos knygos pagal šią temą:
2021 Nelson's Pediatric Antimicrobial Therapy 27th Revised editionDidesnis paveikslėlis
  • Formatas: Paperback / softback, 362 pages, aukštis x plotis x storis: 171x121x19 mm, weight: 299 g
  • Išleidimo metai: 26-Jan-2021
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610024443
  • ISBN-13: 9781610024440
Kitos knygos pagal šią temą:
Pastovi nuoroda: https://www.kriso.lt/db/9781610024440.html
Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.

Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

New in the 27th edition:
  • Continuous updates of drug and dosing changes
  • 4 new chapters
  • Reorganized chapter order to improve functionality


Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of all infectious diseases in children, including COVID-19.
 
Introduction vii
Notable Changes to 2027 Nelson's Pediatric Antimicrobial Therapy, 27th Edition xi
1 Antimicrobial Therapy According to Clinical Syndromes
1(70)
A Skin and Soft Tissue Infections
4(6)
B Skeletal Infections
10(3)
C Eye Infections
13(4)
D Ear and Sinus Infections
17(3)
E Oropharyngeal Infections
20(3)
F Lower Respiratory Tract Infections
23(13)
G Cardiovascular Infections
36(8)
H Gastrointestinal Infections
44(6)
I Genital and Sexually Transmitted Infections
50(5)
J Central Nervous System Infections
55(5)
K Urinary Tract Infections
60(2)
L Miscellaneous Systemic Infections
62(9)
2 Antimicrobial Therapy for Neonates
71(32)
A Recommended Therapy for Selected Neonatal Conditions
74(21)
B Antimicrobial Dosages for Neonates
95(4)
C Aminoglycosides
99(1)
D Vancomycin
100(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
100(3)
3 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
103(28)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
104(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
106(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
108(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
110(21)
4 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
131(8)
5 Preferred Therapy for Specific Fungal Pathogens
139(20)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
140(2)
B Systemic Infections
142(14)
C Localized Mucocutaneous Infections
156(3)
6 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
159(10)
7 Preferred Therapy for Specific Viral Pathogens
169(18)
A Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
170(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
171(1)
C Preferred Therapy for Specific Viral Pathogens
172(15)
8 Choosing Among Antiviral Agents
187(4)
9 Preferred Therapy for Specific Parasitic Pathogens
191(26)
A Selected Common Pathogenic Parasites and Suggested Agents for Treatment
192(2)
B Preferred Therapy for Specific Parasitic Pathogens
194(23)
10 Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
217(2)
11 How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
219(4)
12 Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
223(8)
13 Antibiotic Therapy for Children Who Are Obese
231(4)
14 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
235(2)
15 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
237(16)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
239(6)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
245(2)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
247(1)
D Surgical/Procedure Prophylaxis
248(5)
16 Approach to Antibiotic Allergies
253(10)
17 Antibiotic Stewardship
263(6)
18 Alphabetic Listing of Antimicrobials
269(34)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
271(24)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
295(8)
Appendix: Nomogram for Determining Body Surface Area 303(2)
References 305(26)
Index 331